StonvexLoading…
StonvexStonvexStonvexCore line items from TARS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $162.05M | $451.36M | $299.69M | $181.00M |
Operating Income | $-6.12M | $-70.97M | $-62.99M | $-48.46M |
Net Income | $-6.97M | $-66.42M | $-58.05M | $-20.34M |
EPS (Diluted) | $-0.16 | $-1.59 | $-1.40 | $-1.11 |
Total Assets | $581.13M | $562.16M | $534.56M | $494.99M |
Total Liabilities | $232.18M | $218.73M | $199.48M | $162.38M |
Cash & Equivalents | $102.19M | $183.64M | $112.72M | $96.65M |
Free Cash Flow OCF − CapEx | $-30.47M | $-22.31M | $-35.28M | $-51.63M |
Shares Outstanding | 43.02M | 42.55M | 42.45M | 42.21M |